Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 5671 to 5685 of 7682 results

  1. The evidence on the safety of reinforcement of a permanent stoma with a synthetic or biological mesh to prevent a parastomal hernia shows there are serious but well-recognised complications. The evidence on efficacy is limited in quantity and quality. Therefore, this procedure should not be used unless  special arrangements   are in place for clinical governance, consent, and audit or research.

    Recommendation ID IPG654/1 Question The evidence on the safety of reinforcement of a permanent stoma with a synthetic or biological mesh

    Research recommendation
    Published
    15 November 2019

  2. Referral filtering:- What is the effectiveness and cost effectiveness of the different models for glaucoma filtering (pathways from case-finding to assessment in secondary ophthalmic care) for detecting glaucoma and glaucoma-related conditions (ocular hypertension and suspected glaucoma)?

    Recommendation ID NG81/5 Question Referral filtering:- What is the effectiveness and cost effectiveness of the different models for glaucoma

    Research recommendation
    Published
    18 October 2018

  3. Refractory [Irritable bowel syndrome] (IBS):- What factors contribute to refractory IBS?

    Recommendation ID CG61/3 Question Refractory [Irritable bowel syndrome] (IBS):- What factors contribute to refractory IBS? Any explanatory

    Research recommendation
    Published
    9 June 2015

  4. Red blood cell transfusion thresholds for patients with chronic cardiovascular  disease:- What is the clinical and cost effectiveness of restrictive compared with liberal red blood cell thresholds and targets for patients with chronic cardiovascular disease?

    Recommendation ID NG24/1 Question Red blood cell transfusion thresholds for patients with chronic cardiovascular disease:- What is the

    Research recommendation
    Published
    11 December 2015

  5. Recommendation 3 Barriers and facilitators. Who should take action? Research councils, commissioners and funders. Researchers and investigators.

    Recommendation ID PH47/3 Question Recommendation 3 Barriers and facilitators. Who should take action? Research councils, commissioners

    Research recommendation
    Published
    9 June 2015

  6. Recommendation 1 Research studies and trials. Who should take action? Research councils, commissioners and funders.

    Recommendation ID PH47/1 Question Recommendation 1 Research studies and trials. Who should take action? Research councils, commissioners

    Research recommendation
    Published
    9 June 2015

  7. Relaxation and biofeedback:- What is the effect of relaxation and biofeedback therapies on [Irritable bowel syndrome] (IBS) symptoms and patient-related outcomes?

    Recommendation ID CG61/4 Question Relaxation and biofeedback:- What is the effect of relaxation and biofeedback therapies on [Irritable

    Research recommendation
    Published
    9 June 2015

  8. Repositioning:- When repositioning a person who is at risk of developing a pressure ulcer, what is the most effective position – and optimum frequency of repositioning – to prevent a pressure ulcer developing?

    Recommendation ID CG179/5 Question Repositioning:- When repositioning a person who is at risk of developing a pressure ulcer, what is the

    Research recommendation
    Published
    9 June 2015

  9. Reducing demands on health and social care services:- Do preventive oral health interventions in residential and nursing care homes reduce demands on other health and social care services?

    Recommendation ID NG48/5 Question Reducing demands on health and social care services:- Do preventive oral health interventions in residential

    Research recommendation
    Published
    24 August 2016

  10. Treatment of ESA resistance in people on haemodialysis: What is the most effective type of intervention to treat people on haemodialysis with ESA‑resistant anaemia?

    Recommendation ID NG203/23 Question Treatment of ESA resistance in people on haemodialysis: What is the most effective type of intervention

    Research recommendation
    Published
    30 September 2021

  11. What are the costs associated with best supportive care?

    Recommendation ID TA575/1 Question What are the costs associated with best supportive care? Any explanatory notes(if applicable)

    Research recommendation
    Published
    16 August 2019

  12. What are the clinically and cost-effective surgical approaches to managing complicated acute diverticulitis, including timing of surgery (elective or emergency)?

    Recommendation ID NG147/5 Question What are the clinically and cost-effective surgical approaches to managing complicated acute diverticulitis

    Research recommendation
    Published
    10 February 2020

  13. For people after stroke with communication difficulties, what is the optimal tool for assessing fatigue?

    Recommendation ID NG236/3 Question For people after stroke with communication difficulties, what is the optimal tool for assessing fatigue

    Research recommendation
    Published
    11 January 2024

  14. Topical therapy:- In people of all ages with psoriasis: 1. How should topical therapies be used to maintain disease control i) safely; ii) effectively and iii) what are the health economic implications? 2. What are the risks of 'real life' long term corticosteroid use, are there particular people at risk and what strategies can be used to modify or avoid risks?

    Recommendation ID CG153/5 Question Topical therapy:- In people of all ages with psoriasis: 1. How should topical therapies be used to maintain

    Research recommendation
    Published
    9 June 2015

  15. Topiramate to prevent recurrent cluster headache:- Is topiramate a clinically and cost effective prophylactic treatment for recurrent cluster headache?

    Recommendation ID CG150/3 Question Topiramate to prevent recurrent cluster headache:- Is topiramate a clinically and cost effective prophylactic

    Research recommendation
    Published
    9 June 2015